A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease

Background: Five types of HIF-PHIs have been authorized for anemia treatment in CKD patients in China and Japan. These are enarodustat, roxadustat, daprodustat, vadadustat, and molidustat. How effectively they compare to ESAs about clinical results in CKD-DD patients is uncertain. This study examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun, Shou, Xinyang, Xu, Yanyan, Jin, Lie, Zhu, Chaoyong, Ye, Xiaolan, Mei, Ziwei, Chen, Peipei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085583/
https://www.ncbi.nlm.nih.gov/pubmed/36988549
http://dx.doi.org/10.18632/aging.204611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085583/
https://www.ncbi.nlm.nih.gov/pubmed/36988549
http://dx.doi.org/10.18632/aging.204611

Ejemplares similares